Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Inc. (SGMT) is a healthcare company (biotechnology) based in the United States. The share price is $9.90, down 2.27% on the day, which values the company at $712.16M. Price as of 17 Nov 2026, 19:14 UTC, from Yahoo Finance.

Key facts

Share price
$9.90−2.27% today
Market value
$712.16M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Sagimet Biosciences Inc. in more detail

SGMT trades at -6.8× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Weak Piotroski score.

3 of the superinvestors tracked here hold SGMT, including Zhang Lei (0.7% of the portfolio), Julian and Felix Baker (0.0% of the portfolio), Andrew Spokes (0.0% of the portfolio).

Superinvestors holding SGMT

3 of the investors tracked here report a position in their latest 13F filing.

Sagimet Biosciences Inc. (SGMT): questions and answers

What is Sagimet Biosciences Inc.'s market cap?

Sagimet Biosciences Inc. is valued at $712.16M at a share price of $9.90.

Does SGMT pay a dividend?

Sagimet Biosciences Inc. does not currently pay a regular dividend.

Which famous investors own SGMT?

In their latest quarterly filings, Zhang Lei (0.7% of the portfolio), Julian and Felix Baker (0.0% of the portfolio), Andrew Spokes (0.0% of the portfolio) hold SGMT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Sagimet Biosciences Inc. (SGMT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SGMT

Underlying data: Yahoo Finance; company filings with the SEC.